SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories
Dr Reddys Laboratories
BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jun 30, 17:00
3550.55
29.65 (0.84%)
VOLUME 12,380
LIVE
NSE
Jun 30, 17:00
3559.45
38.3 (1.09%)
VOLUME 395,298

Stock Advice on Dr Reddys Laboratories

Select Year: 2013 |  2012 |  2011 | 2010 | 2009 | 2008 | 2007 | 2000-2006
Buy Lupin, Dr Reddy's Labs, BPCL: Ashish Chaturmohta 

3.21 pm | 26 Jun 2015 |  Source: CNBC-TV18

Ashish Chaturmohta of Fortune Eqity Broker recommends buying Lupin, Dr Reddy's Labs and BPCL....

Pick L&T, BHEL, ICICI Bank, Sun Pharma: Sharmila Joshi 

3.56 pm | 25 Jun 2015 |  Source: CNBC-TV18

Sharmila Joshi of sharmilajoshi.com recommends picking L&T, BHEL, ICICI Bank, HDFC Bank, Sun Pharma and Dr Reddy's Labs....

Exit Natco Pharma, buy Sun Pharma, Glenmark: Sukhani 

12.33 pm | 18 Jun 2015 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends exiting Natco Pharma and advises buying Glenmark Pharma, Dr Reddy's Laboratories and Sun Pharma at low...

Scaled down FY16-end Nifty target to 9300: PhillipCap 

3.19 pm | 17 Jun 2015 |  Source: CNBC-TV18

While maintaining that incrementally there have been a few macro positive in terms of coal dispatches and industrial output over the past few days, Na...

Buy Dr Reddy's Laboratories: Pritesh Mehta 

4.04 pm | 15 Jun 2015 |  Source: CNBC-TV18

Pritesh Mehta of IIFL advises buying Dr Reddy's Laboratories....

Prefer Infosys, TCS, Axis Bank, HDFC Bank: Gaurang Shah 

4.26 pm | 12 Jun 2015 |  Source: CNBC-TV18

Gaurang Shah of Geojit BNP Paribas Financial Services is of the view that one may prefer Infosys, HCL Technologies and Tata Consultancy Services from ...

Wockhardt in downtrend, looks weak: Sudarshan Sukhani 

12.18 pm | 11 Jun 2015 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that Wockhardt is in a downtrend and looks weak....

Glenmark, Dr Reddy's top picks: R Sreesankar 

1.08 pm | 20 May 2015 |  Source: CNBC-TV18

R Sreesankar, Head-Institutional Equities at Prabhudas Lilladher is of the view that Glenmark Pharma, Dr Reddy's Laboratories and Aurobindo Pharma are...

12
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.